Jeremy Grantham Zoetis Inc. Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $30.8 Billion
- Q1 2025
A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Zoetis Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 4,300 shares of ZTS stock, worth $728,506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,300Holding current value
$728,506% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ZTS
# of Institutions
2,113Shares Held
421MCall Options Held
1.98MPut Options Held
1.03M-
Vanguard Group Inc Valley Forge, PA41.6MShares$7.04 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.24 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.35 Billion0.14% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$2.69 Billion2.42% of portfolio
-
Morgan Stanley New York, NY12.7MShares$2.16 Billion0.15% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $79.3B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...